When pandemics strike, drug re-purposing becomes critical for faster development of therapies. However, assembling all of the critical information and connections around new proteins, new viruses, targets, pathways, and clinical information can be challenging. CAS leverages their unique connections across the world's science for novel knowledge graphs that identify top clinical candidates to re-purpose for COVID-19 therapies.
This complimentary CAS insights report details the CAS Biomedical Knowledge Graph and demonstrates how we have used it to provide solutions for a real-world problem – drug discovery in COVID-19.
